TVRD Latest Headlines

Tvardi’s TTI-109 Phase 1 Data Shows Up to 60% Immune Cell Reduction and Superior Tolerability Over TTI-101

Market Chameleon (Wed, 8-Jul 11:08 AM)

Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today?

at www.tipranks.com (Wed, 8-Jul 2:12 PM)

Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Tvardi Therapeutics (TVRD) and COMPASS Pathways (CMPS)

at www.tipranks.com (Wed, 8-Jul 6:10 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tvardi Therapeutics (TVRD), Resmed (RMD) and Zimmer Biomet Holdings (ZBH)

at www.tipranks.com (Wed, 8-Jul 6:01 AM)

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD), Teva Pharmaceutical (TEVA) and BridgeBio Pharma (BBIO)

at www.tipranks.com (Wed, 8-Jul 4:50 AM)

TTI-109 Phase 1 Results Show Meaningful Reductions in STAT3-Driven Immune Cells—Path Cleared for Dermatologic and GI Trials Pending Funding

Market Chameleon (Tue, 7-Jul 10:29 AM)

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Tvardi Therapeutics (TVRD)

at www.tipranks.com (Tue, 7-Jul 12:10 PM)

Tvardi Therapeutics Reports Phase 1 Data for TTI-109

at www.tipranks.com (Tue, 7-Jul 7:28 AM)